Informations générales (source: ClinicalTrials.gov)

NCT03102905 Statut inconnu
Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema? (REPLIPO)
Observational
  • Exanthème
Centre Hospitalier Universitaire, Amiens (Voir sur ClinicalTrials)
décembre 2016
juin 2017
29 juin 2024
To look for the replication of HHV6 by PCR in the skin, in these patients with haemopathies presenting an exanthema. This will make it possible to evaluate the prevalence of the positivity of this PCR in the skin. Then the investigator can investigate whether there is an association between the positivity of HHV6 PCR in the blood and / or skin and the viral etiology of the exanthema. If this association exists, it will make it possible to improve the diagnosis in the context of the exanthema and thus to improve the therapeutic management of these patients.
 Voir le détail

Etablissements

Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHU Amiens Picardie - 80054 - Amiens - Picardie - France Guillaume CHABY, Dr En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Supported for any type of hemopathy.

- Allograft, autografted or ungrafted haematopoietic stem cells

- Having presented an exanthema during hospitalization, for which a cutaneous biopsy
had been performed

- Having had a blood test of the HHV6 virus by PCR at least within the previous 40
days or following the rash.

- Age greater than or equal to 18 years

- Patient informed of the protocol by post, not having refused within one month of
sending the said courier.


- Patient who refused the search.

- Patient whose HHV6 PCR in the blood was carried out at a distance of more than 40
days from the skin biopsy.